Related Experiment Videos
[Polymyositis in childhood]
J Marín1, F Noguera, A Cabello
1Unidad de Neurología Infantil, Hospital 12 de Octubre, Madrid, España.
Insights
Idiopathic inflammatory myopathies, like polymyositis, are rare in children. Steroid treatment can improve symptoms, but outcomes vary, especially in infantile cases.
Area of Science:
- Pediatric Rheumatology
- Neuromuscular Disorders
Background:
- Idiopathic inflammatory myopathies (IIMs) are rare in infancy, presenting diagnostic challenges.
- Polymyositis in children exhibits significant clinical variability.
Observation:
- Five pediatric cases of polymyositis were analyzed.
- Two distinct groups emerged: infantile polymyositis (generalized hypotonia) and childhood polymyositis (proximal weakness).
- Elevated CPK, myopathic EMG, and inflammatory myopathy on biopsy were consistent findings.
Findings:
- Infantile polymyositis presents with generalized hypotonia.
- Childhood polymyositis mirrors adult presentations, with one case developing juvenile chronic arthritis.
- Corticosteroid treatment generally led to clinical improvement, though outcomes were variable and sometimes partial.
Implications:
- Polymyositis is exceptionally rare before puberty, with a wide clinical spectrum.
- Early diagnosis and treatment are crucial for managing pediatric polymyositis.
- While corticosteroids are beneficial, their efficacy may be less favorable compared to dermatomyositis.
Introduction And Objective:
Idiopathic inflammatory myopathies are very rare in infancy. We present five cases of polymyositis in children in which the clinical variability and difficulty in diagnosis that occurs with this disorder are clearly seen, and analyze their response to steroid treatment.
Clinical Cases:
We can distinguish two groups of patients: the first is formed of the case of a two and a half month old baby with generalized hypotonia; and the second includes the other four cases, children of between 2 and 8 years old with weakness, which was mainly proximal. One of the second group later developed juvenile chronic arthritis. In all cases there was a raised CPK and a myopathic EMG, with or without spontaneous muscle activity. Muscle biopsy showed inflammatory myopathy. The first group corresponds to so-called infantile polymyositis which is characterized by generalized hypotonia. The second group includes older children in whom the clinical features of the disorder are similar to those in adults. The association of other autoimmune diseases with infantile polymyositis is exceptional. All cases show more or less improvement with corticosteroids.
Conclusions:
The polymyositis are extremely rare before puberty and have a broad clinical spectrum. Congenital cases have been described in infants and in older children. The biopsy results are usually unexpected. Treatment with corticosteroids leads to clinical improvement which may be only partial and is less favorable than in the dermatomyositis.